- Drug-Eluting Stent
- Bioresorbable Stent
- Bare Metal Stent
- Covered Stent
- Others
Coronary Stent Market size was valued at USD 8,923.2 million in 2022 and is poised to grow at a significant CAGR of 3.6% over 2023–2029. Coronary stents (CS) are expandable tubular metallic devices that are used to widen blocked or narrowed coronary arteries that are clogged due to an underlying atherosclerosis disease. This revascularization procedure is termed a percutaneous coronary intervention (PCI) or coronary angioplasty with stent placement. A coronary angioplasty is a procedure. The term "angioplasty" means using a balloon to stretch open a narrowed or blocked artery. However, most modern angioplasty procedures also involve inserting a short wire-mesh tube, called a stent, into the artery during the procedure. These arteries can become narrowed and hardened in older people, which can cause coronary heart disease. Coronary angioplasties are also often used as an emergency treatment after a heart attack or angina. Increasing technological advancement, rising incidence of coronary artery disease, the subsequent growth in the number of PCI procedures, increasing demand for minimally invasive procedures, and rising geriatric population are driving the global coronary stent market growth. The increasing prevalence of cardiovascular drugs diseases is boosting the global coronary stent market trend at a significant rate. For instance, according to the Centers for Disease Control and Prevention (CDC), coronary heart disease, the most common type of heart disease, killed 382,820 people in 2020 in the USA and about 20.1 million adults age 20 and older had CAD (about 7.2%). Along with that emerging global markets and global players are influencing the global coronary stent market growth. However, the availability of alternative treatment methods for coronary artery diseases, stringent regulations for product approval, and the increasing number of product failures, and product recalls may hamper the global coronary stent market growth. Geographically, North America held the major market share in the global market and is expected to dominate the market in the forecasted years.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The increasing prevalence of coronary heart disease will boost the overall market growth in the upcoming years. It is attributed to unhealthy lifestyles, growing stress levels, and increasing alcohol consumption. Heart disease is one of the leading causes of death worldwide. For example, according to the Centers for Disease Control and Prevention (CDC), one person dies every 34 seconds in the United States from cardiovascular disease and around 697,000 people in the United States died from heart disease in 2020. Also, heart disease cost the United States about $229 billion each year from 2017 to 2018 including the cost of health care services, medicines, and lost productivity due to death. Hence, it will drive the global coronary stent market.
The coronary stent market is projected to expand at a CAGR of 3.6% during the forecast period
Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, MicroPort Scientific Corporation, R. Bard, Inc., Cook Medical, Biosensors International Group
Global is the fastest-growing region for coronary stent market
1. Executive Summary |
2. Global Coronary Stent Market Introduction |
2.1. Global Coronary Stent Market – Taxonomy |
2.2. Global Coronary Stent Market – Definitions |
2.2.1. By Product Type |
2.2.2. By Mode of Delivery |
2.2.3. By End User |
2.2.4. By Region |
3. Global Coronary Stent Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Coronary Stent Market Dynamic Factors - Impact Analysis |
3.6. Global Coronary Stent Market – Competition Landscape |
3.7. Epidemiology |
4. Global Coronary Stent Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Coronary Stent Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
5.1. Drug-Eluting Stent |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Bioresorbable Stent |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Bare Metal Stent |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Covered Stent |
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Others |
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6. Global Coronary Stent Market, By Mode of Delivery, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.1. Self-expandable |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Balloon-expandable |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Coronary Stent Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.1. Hospitals |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Ambulatory Surgical Centers |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Specialty Clinics |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Coronary Stent Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
8.1. North America |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Middle East and Africa |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Coronary Stent Market - Opportunity Analysis Index, By Product Type, By Mode of Delivery, By End User, and Region, 2023 - 2029 |
9. North America Coronary Stent Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
9.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Drug-Eluting Stent |
9.1.2. Bioresorbable Stent |
9.1.3. Bare Metal Stent |
9.1.4. Covered Stent |
9.1.5. Others |
9.2. Mode of Delivery Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Self-expandable |
9.2.2. Balloon-expandable |
9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Hospitals |
9.3.2. Ambulatory Surgical Centers |
9.3.3. Specialty Clinics |
9.3.4. Others |
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. USA |
9.4.2. Canada |
9.5. North America Coronary Stent Market - Opportunity Analysis Index, By Product Type, By Mode of Delivery, By End User, and Country, 2023 - 2029 |
9.6. North America Coronary Stent Market Dynamics – Trends |
10. Europe Coronary Stent Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Drug-Eluting Stent |
10.1.2. Bioresorbable Stent |
10.1.3. Bare Metal Stent |
10.1.4. Covered Stent |
10.1.5. Others |
10.2. Mode of Delivery Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Self-expandable |
10.2.2. Balloon-expandable |
10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Hospitals |
10.3.2. Ambulatory Surgical Centers |
10.3.3. Specialty Clinics |
10.3.4. Others |
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Germany |
10.4.2. UK |
10.4.3. France |
10.4.4. Spain |
10.4.5. Italy |
10.4.6. Rest of Europe |
10.5. Europe Coronary Stent Market - Opportunity Analysis Index, By Product Type, By Mode of Delivery, By End User, and Country, 2023 - 2029 |
10.6. Europe Coronary Stent Market Dynamics – Trends |
11. Asia-Pacific Coronary Stent Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
11.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Drug-Eluting Stent |
11.1.2. Bioresorbable Stent |
11.1.3. Bare Metal Stent |
11.1.4. Covered Stent |
11.1.5. Others |
11.2. Mode of Delivery Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Self-expandable |
11.2.2. Balloon-expandable |
11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Hospitals |
11.3.2. Ambulatory Surgical Centers |
11.3.3. Specialty Clinics |
11.3.4. Others |
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.4.1. China |
11.4.2. India |
11.4.3. Japan |
11.4.4. ASEAN |
11.4.5. Australia & New Zealand |
11.4.6. Rest of Asia-Pacific |
11.5. Asia-Pacific Coronary Stent Market - Opportunity Analysis Index, By Product Type, By Mode of Delivery, By End User, and Country, 2023 - 2029 |
11.6. Asia-Pacific Coronary Stent Market Dynamics – Trends |
12. Latin America Coronary Stent Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
12.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Drug-Eluting Stent |
12.1.2. Bioresorbable Stent |
12.1.3. Bare Metal Stent |
12.1.4. Covered Stent |
12.1.5. Others |
12.2. Mode of Delivery Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Self-expandable |
12.2.2. Balloon-expandable |
12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Hospitals |
12.3.2. Ambulatory Surgical Centers |
12.3.3. Specialty Clinics |
12.3.4. Others |
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Brazil |
12.4.2. Mexico |
12.4.3. Rest of Latin America |
12.5. Latin America Coronary Stent Market - Opportunity Analysis Index, By Product Type, By Mode of Delivery, By End User, and Country, 2023 - 2029 |
12.6. Latin America Coronary Stent Market Dynamics – Trends |
13. Middle East and Africa Coronary Stent Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
13.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Drug-Eluting Stent |
13.1.2. Bioresorbable Stent |
13.1.3. Bare Metal Stent |
13.1.4. Covered Stent |
13.1.5. Others |
13.2. Mode of Delivery Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Self-expandable |
13.2.2. Balloon-expandable |
13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Hospitals |
13.3.2. Ambulatory Surgical Centers |
13.3.3. Specialty Clinics |
13.3.4. Others |
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Gulf Cooperation Council (GCC) Countries |
13.4.2. South Africa |
13.4.3. Rest of MEA |
13.5. MEA Coronary Stent Market - Opportunity Analysis Index, By Product Type, By Mode of Delivery, By End User, and Country, 2023 - 2029 |
13.6. MEA Coronary Stent Market Dynamics – Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Key Product Types, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. Abbott |
14.2.2. Medtronic |
14.2.3. Boston Scientific Corporation |
14.2.4. Terumo Corporation |
14.2.5. B Braun Melsungen AG |
14.2.6. Biotronik |
14.2.7. Stentys SA |
14.2.8. MicroPort Scientific Corporation |
14.2.9. C. R. Bard, Inc. |
14.2.10. Cook Medical |
14.2.11. Biosensors International Group |
15. Research Methodology |
16. Key Assumptions and Acronyms |